Brown, M.G., Dokun, A.O., Heusel, J.W., Smith, H.R., Beckman, D.L., Blattenberger, E.A., Dubbelde, C.E., Stone, L.R., Scalzo, A.A., and Yokoyama, W.M.: Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001, 292:934–937.
Long, E.O.: Negative signalling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 2008, 224:70–84.
Robbins, S.H., and Brossay, L.: NK cell receptors: emerging roles in host defense against infectious agents. Microbes Infect. 2002, 4:1523–1530.
Trowsdale, J.: Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001, 15:363–374.
Vilches, C., and Parham, P.: KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 2002, 20:217–251.
Vivier, E., Raulet, D.H., Moretta, A., Caligiuri, M.A., Zitvogel, L., Lanier, L.L., Yokoyama, W.M., and Ugolini, S.: Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44–49.
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., and Ugolini, S.: Functions of natural killer cells. Nat. Immunol. 2008, 9:503–510.
3‑27 NK cells express activating receptors that recognize ligands induced on infected cells or tumor cells.
Brandt, C.S., Baratin, M., Yi, E.C., Kennedy, J., Gao, Z., Fox, B., Haldeman, B., Ostrander, C.D., Kaifu, T., Chabannon, C., et al.: The B7 family member B7‑H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 2009, 206:1495–1503.
Gasser, S., Orsulic, S., Brown, E.J., and Raulet, D.H.: The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005, 436:1186–1190.
Gonzalez, S., Groh, V., and Spies, T.: Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol. 2006, 298:121–138.
Lanier, L.L.: Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 2008, 9:495–502.
Moretta, L., Bottino, C., Pende, D., Castriconi, R., Mingari, M.C., and Moretta, A.: Surface NK receptors and their ligands on tumor cells. Semin. Immunol. 2006, 18:151–158.
Parham, P.: MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 2005, 5:201–214.
Raulet, D.H., and Guerra, N.: Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat. Rev. Immunol. 2009, 9:568–580.